Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Nebert

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Progress in Lipid Research|June 14, 2017
Aryl hydrocarbon receptor (AHR): "pioneer member" of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of "sensors" of foreign and endogenous signalsDaniel W Nebert
Environmental Health Perspectives|December 8, 2004
Conflicts of interests: declarations for allDaniel W Nebert
Journal of Biochemical and Molecular Toxicology|June 25, 2005
Role of host susceptibility to toxicity and cancer caused by pesticides: cytochromes P450Daniel W Nebert
Human Genomics|August 27, 2009
Given the complexity of the human genome, can 'personalised medicine' or 'individualised drug therapy' ever be achieved?Daniel W Nebert
Toxicology|December 31, 2002
Transcription factors and cancer: an overviewDaniel W Nebert
Human Mutation|November 21, 2002
Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypesDaniel W Nebert
Toxicology and Applied Pharmacology|June 29, 2005
Inter-individual susceptibility to environmental toxicants--a current assessmentDaniel W Nebert
Annual Review of Pharmacology and Toxicology|October 3, 2023
Gene-Environment Interactions: My Unique JourneyDaniel W Nebert
American Journal of Physiology. Cell Physiology|December 13, 2005
Comparison of gene expression in cell culture to that in the intact animal: relevance to drugs and environmental toxicants. Focus on "development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes"Daniel W Nebert
Pharmacology & Therapeutics|February 19, 2017
Personalized medicine: Genetic risk prediction of drug responseGe Zhang, Daniel W Nebert
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Progress in Lipid Research|June 14, 2017
Aryl hydrocarbon receptor (AHR): "pioneer member" of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of "sensors" of foreign and endogenous signalsDaniel W Nebert
Environmental Health Perspectives|December 8, 2004
Conflicts of interests: declarations for allDaniel W Nebert
Journal of Biochemical and Molecular Toxicology|June 25, 2005
Role of host susceptibility to toxicity and cancer caused by pesticides: cytochromes P450Daniel W Nebert
Human Genomics|August 27, 2009
Given the complexity of the human genome, can 'personalised medicine' or 'individualised drug therapy' ever be achieved?Daniel W Nebert
Toxicology|December 31, 2002
Transcription factors and cancer: an overviewDaniel W Nebert
Human Mutation|November 21, 2002
Proposal for an allele nomenclature system based on the evolutionary divergence of haplotypesDaniel W Nebert
Toxicology and Applied Pharmacology|June 29, 2005
Inter-individual susceptibility to environmental toxicants--a current assessmentDaniel W Nebert
Annual Review of Pharmacology and Toxicology|October 3, 2023
Gene-Environment Interactions: My Unique JourneyDaniel W Nebert
American Journal of Physiology. Cell Physiology|December 13, 2005
Comparison of gene expression in cell culture to that in the intact animal: relevance to drugs and environmental toxicants. Focus on "development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes"Daniel W Nebert
Pharmacology & Therapeutics|February 19, 2017
Personalized medicine: Genetic risk prediction of drug responseGe Zhang, Daniel W Nebert
Pageof 17